PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Global One Health initiative, The Ohio State University, Columbus, OH, USA.\', \'Department of Pharmacognosy, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana.\', \'Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Campbell University, Buies Creek, North Carolina, USA.\', \'Division of Clinical Research, Brazilian National Cancer Institute, INCA, Rio de Janeiro, Brazil.\', \'Division of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa.\', \'CP+ Associates GmbH, Basel, Switzerland.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/bcp.14981
?:doi
?:hasPublicationType
?:journal
  • British journal of clinical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34272755
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.543
?:rankingScore_hIndex
  • 126
?:title
  • Traditional medicines for COVID-19: Perspectives from clinical pharmacologists.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34272755>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34272755>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all